TY  - JOUR
AU  - Calleja, José Luis
AU  - Delgado, Salvadora
AU  - del Val, Adolfo
AU  - Hervás, Antonio
AU  - Larraona, José Luis
AU  - Terán, Álvaro
AU  - Cucala, Mercedes
AU  - Mearin, Fermín
AU  - Colon Cancer Study Group
PY  - 2015
DO  - 10.1007/s00384-015-2461-x
UR  - http://hdl.handle.net/10668/9676
T2  - International journal of colorectal disease
AB  - The purpose of the study was to evaluate the efficacy of preoperative intravenous (IV) ferric carboxymaltose (FCM) administration vs. no-IV iron in colon cancer (CC) anemic patients undergoing elective surgery with curative intention. This was a...
LA  - en
KW  - Colon cancer surgery
KW  - Ferric carboxymaltose
KW  - Iron deficiency anemia
KW  - Iron intravenous administration
KW  - Aged
KW  - Anemia
KW  - Blood Transfusion
KW  - Colonic Neoplasms
KW  - Erythrocyte Indices
KW  - Female
KW  - Ferric Compounds
KW  - Hemoglobins
KW  - Humans
KW  - Iron
KW  - Length of Stay
KW  - Male
KW  - Maltose
KW  - Postoperative Complications
KW  - Transplantation, Homologous
KW  - Treatment Outcome
TI  - Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.
TY  - research article
VL  - 31
ER  -